Use of &ggr;-tocopherol and its oxidative metabolite LLU-&agr; in the treatment of disease
US6410589B1 · kind B1 · utility
12Cited by
9References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 21, 2001 |
| Grant date | Jun 25, 2002 |
| Priority date | — |
| Expiry date | Mar 21, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is generally related to the discovery of the therapeutic benefit of administering &ggr;-tocopherol and &ggr;-tocopherol derivatives. More specifically, the use of &ggr;-tocopherol and racemic LLU-&agr;, (S)-LLU-&agr;, or &ggr;-tocopherol derivatives as antioxidants and nitrogen oxide scavengers which treat and prevent high blood pressure, thromboembolic disease, cardiovascular disease, cancer, natriuretic disease, the formation of neuropathological lesions, and a reduced immune system response are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.